Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
PerkinElmer is a diagnostics & research business based in the US. PerkinElmer shares (PKI) are listed on the NYSE and all prices are listed in US Dollars. PerkinElmer employs 16,700 staff and has a trailing 12-month revenue of around $3.3 billion.
Finder Award
SoFi Invest
Finder Award
eToro
tastytrade
| Latest market close | $127.58 |
|---|---|
| 52-week range | $113.34 - $181.29 |
| 50-day moving average | $131.48 |
| 200-day moving average | $136.63 |
| Wall St. target price | $159.79 |
| PE ratio | 30.5098 |
| Dividend yield | $0.28 (0.23%) |
| Earnings per share (TTM) | $4.10 |
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $127.58 from 2023-03-24
| 1 week (2023-03-16) | N/A |
|---|---|
| 1 month (2023-02-23) | N/A |
| 3 months (2022-12-27) | -9.00% |
| 6 months (2022-09-23) | N/A |
| 1 year (2022-03-24) | -28.86% |
|---|---|
| 2 years (2021-03-26) | -1.47% |
| 3 years (2020-03-27) | 71.30% |
| 5 years (2018-03-27) | 71.12% |
Valuing PerkinElmer stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of PerkinElmer's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
| Revenue TTM | $3.3 billion |
|---|---|
| Operating margin TTM | 25.96% |
| Gross profit TTM | $2 billion |
| Return on assets TTM | 3.69% |
| Return on equity TTM | 7.06% |
| Profit margin | 17.19% |
| Book value | $58.46 |
| Market capitalisation | $15.8 billion |
TTM: trailing 12 months
Dividend payout ratio: 3.53% of net profits
Recently PerkinElmer has paid out, on average, around 3.53% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.23% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), PerkinElmer shareholders could enjoy a 0.23% return on their shares, in the form of dividend payments. In PerkinElmer's case, that would currently equate to about $0.28 per share.
While PerkinElmer's payout ratio might seem low, this can signify that PerkinElmer is investing more in its future growth.
PerkinElmer's most recent dividend payout was on 11 May 2023. The latest dividend was paid out to all shareholders who bought their shares by 19 April 2023 (the "ex-dividend date").
PerkinElmer's shares were split on a 2:1 basis on 3 June 2001. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your PerkinElmer shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for PerkinElmer shares which in turn could have impacted PerkinElmer's share price.
Over the last 12 months, PerkinElmer's shares have ranged in value from as little as $113.3379 up to $181.2914. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while PerkinElmer's is 1.0958. This would suggest that PerkinElmer's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection, and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.
Here’s what happens to your securities if your brokerage fails, and how your assets are protected by SIPC and FDIC.
Learn about buying physical gold, plus stocks and ETFs, to learn how you can add gold exposure to your portfolio.
Several ETFs have exposure to Silicon Valley Bank, but it appears minimal.
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
The 16th largest US bank has collapsed, but its impact on your portfolio could be limited depending on what you own.
Steps to investing in the Vanguard (VTI) Total Stock Market ETF.
Everything we know about the Neuraxis IPO, plus information on how to buy in.
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.